- Presented by:
- Roy F. Chemaly, MD, MPH, FIDSA, FACP
- Raymund R. Razonable, MD
Click on a program title below to view the on-demand webcast. CME and/or CNE accreditation has expired for archived programs.
This program reviews the advantages and disadvantages of different TB testing methods in various clinical settings and the relative financial strengths and weaknesses of IGRAs and the TST, leading into a discussion of strategy for presenting a financial justification to switch from the TST to an IGRA.
The goal of this activity is to educate nurses about how to evaluate all of the considerations that are associated with TB testing (cost, logistics, test performance) to appropriately determine the best test for their institution and employees. The target audience of this program are occupational health and employee health professionals involved in the regular screening of employees for Latent Tuberculosis Infection (LTBI).
The goal of this activity is to convey information to physicians and health care professionals in the field of transplantation and to encourage group participation and discussion. At the end of this activity, participants should be able to determine the epidemiology and incidence of TB infection in immunocompromised patients, differentiate between the 3 available latent TB testing methods, and identify the clinical utility of IGRAs when testing immunocompromised patients for TB.
This program is intended for rheumatologists and other healthcare professionals treating patients with rheumatic diseases and opportunistic infections in the biological setting. At the end of this activity, participants should be able to manage complex case scenarios of opportunistic infections in rheumatic disease patients and discuss appropriate clinical management of patients who develop infections during therapy.